Canadian Life Companies Split Corp.
TSX:LFE.TOAsset Management
+$0.11 today
- Market cap
- $162.19M
- Beta
- 2.23
- P/E (TTM)
- 4.8
- EPS (TTM)
- $1.75
- Dividend yield
- 14.37%
Volume 0.13M
Average 0.10M
LFE.TO Interest Expense
Cost of servicing the company's debt during the period.
Canadian Life Companies Split Corp.TSX: LFE.TO
Interest Expense · Q4 FY2025 · quarter ended Nov 2025
Interest expense remains negative
Q4 FY2025 interest expense was CA$5.38M, compared with CA$0 a year earlier.
Context
- Interest expense amounted to 88.8% of revenue in FY2025, up 88.8 pp from a year earlier.
- Interest expense increased in 1 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
Sources:Income StatementText generated from reported figures; not investment advice.
Interest Expense history
CAD · from the income statement
- Latest · FY2025
- 9.25M CAD
- Year-over-year change
- —
| Period | Period end | Interest Expense | YoY change |
|---|---|---|---|
| FY2025 | 2025-11-30 | 9.25M | — |
| FY2024 | 2024-11-30 | 0 | — |
| FY2023 | 2023-11-30 | 0 | — |
| FY2022 | 2022-11-30 | 0 | — |
| FY2021 | 2021-11-30 | 0 | — |
Interest Expense vs competitors
How LFE.TO compares with its peers on the latest reported figures
- LFE.TO's FY2025 interest expense of CA$9.25M is the 3rd highest of the 8 companies compared; the peer median is CA$2.7M.
- Interest expense amounts to 88.8% of revenue for LFE.TO, versus a peer median of 48.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| FY2025 | CA$82.7M | — | — | 93.7% | |
| FY2025 | CA$20.36M | +26.4% | — | 67.2% | |
| FY2025 | CA$9.25M | — | — | 88.8% | |
| FY2025 | CA$4.5M | — | — | 48.9% | |
| FY2025 | CA$2.7M | — | — | 96.8% | |
| LTM Mar 2026 | CA$14K | +0.0% | -4.4% | 0.3% | |
RS.TOReal Estate Split Corp. | FY2025 | CA$0 | -100.0% | — | 0.0% |
| FY2025 | CA$0 | — | — | 0.0% | |
| Peer median (excluding LFE.TO) | CA$2.7M | +0.0% | -4.4% | 48.9% | |
Competitors are the stored peer set for LFE.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Nov 2021 | FY2022 Nov 2022 | FY2023 Nov 2023 | FY2024 Nov 2024 | FY2025 Nov 2025 |
|---|---|---|---|---|---|
| Revenue | 8.51M | 9.95M | 8.22M | 55.94M | 10.41M |
| Cost of Revenue | 1.6M | 1.43M | 1.45M | 1.43M | 1.73M |
| Gross Profit | 6.91M | 8.52M | 6.77M | 54.77M | 8.68M |
| Gross Margin | 81.2% | 85.6% | 82.4% | 97.9% | 83.4% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 422.88K | 1.48M | 408.8K | 379.51K | 393.31K |
| Operating Expenses | 1.62M | 1.48M | 576.41K | 576K | (20.36M) |
| Depreciation & Amortization | 0 | 0 | 0 | 0 | 0 |
| EBITDA | 27.18M | 3.22M | 21.29M | 54.19M | 30.82M |
| EBITDA Margin | 319.5% | 32.4% | 259.0% | 96.9% | 296.0% |
| Operating Income | 27.54M | 3.22M | 21.28M | 54.19M | 29.04M |
| Operating Margin | 323.7% | 32.4% | 258.8% | 96.9% | 278.9% |
| Interest Income | 207 | 171.28K | 378.77K | 416.93K | 7.42M |
| Interest Expense | 0 | 0 | 0 | 0 | 9.25M |
| Other Income / Expenses | (8.83M) | (8.37M) | (9.54M) | (8.85M) | (7.47M) |
| Income Before Tax | 18.71M | (5.14M) | 11.74M | 45.6M | 21.57M |
| Pre-Tax Margin | 219.9% | -51.7% | 142.8% | 81.5% | 207.1% |
| Income Tax Expense | 36.81K | 68.46K | (2.47K) | 27.11K | 0 |
| Net Income | 18.67M | 3.43M | 11.74M | 45.58M | 21.57M |
| Net Margin | 219.5% | 34.4% | 142.8% | 81.5% | 207.1% |
| EPS (Basic) | 1.33 | (0.38) | 0.90 | 3.83 | 1.74 |
| EPS (Diluted) | 1.33 | (0.38) | 0.99 | 3.83 | 1.74 |
| Weighted Avg Shares | 12.78M | 12.46M | 13.03M | 11.91M | 12.41M |
| Weighted Avg Shares (Diluted) | 12.78M | 12.46M | 11.85M | 11.91M | 12.41M |
Canadian Life Companies Split Corp.
TSX:LFE.TO
Intrinsic Alpha fair value
Locked
Current Price
$9.48
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.